Stephen Chapman
Chief Executive Officer presso NATERA, INC.
Patrimonio netto: 21 M $ in data 31/03/2024
Posizioni attive di Stephen Chapman
Società | Posizione | Inizio | Fine |
---|---|---|---|
NATERA, INC. | Director/Board Member | 02/01/2019 | - |
Chief Executive Officer | 02/01/2019 | - | |
Chief Operating Officer | 01/07/2017 | 02/01/2019 | |
Corporate Officer/Principal | 01/12/2010 | 01/07/2017 | |
President | 02/01/2019 | 18/09/2023 |
Storia della carriera di Stephen Chapman
Precedenti posizioni note di Stephen Chapman
Società | Posizione | Inizio | Fine |
---|---|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2003 | 01/01/2010 |
University of California, Los Angeles | Corporate Officer/Principal | - | - |
Formazione di Stephen Chapman
University of California, Los Angeles | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Posizioni
Corporate Officer/Principal | 3 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Settori
Health Technology | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
NATERA, INC. | Health Technology |
Aziende private | 1 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Stephen Chapman
- Esperienza